Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001829126-25-001316
Filing Date
2025-02-28
Accepted
2025-02-28 11:31:49
Documents
1
Period of Report
2025-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 ownership.html 3  
1 FORM 3 ownership.xml 3 2151
  Complete submission text file 0001829126-25-001316.txt   3734
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 42, JALAN BPM9,TAMAN BUKIT PIATU MUTIARA BUKIT BARU MELEKA N8 75150
Business Address
Chong Kwang Fock (Reporting) CIK: 0001893076 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 25685139